Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Natural products for the treatment of sleep disorders

Sep. 21, 2007

mGlu2/3 receptor activation with LY-2140023 improves schizophrenia symptoms

Sep. 20, 2007

Sosei completes phase II proof-of-principle trial of AD-337 for FMS

Sep. 20, 2007

Recent patents describe novel agents for psychiatric disorders

Sep. 20, 2007

Snapshots of clinical results in sleep research

Sep. 19, 2007

Patient enrollment completed for Sciele Pharma's pivotal phase III trial of glycopyrrolate

Sep. 19, 2007

Cannasat Therapeutics' pain therapy delivered with IntelGenx technology in phase I trial

Sep. 19, 2007

Preclinical data on potential targets for the development of agents for sleep disorders

Sep. 19, 2007

Phosphagenics submits IND for transdermal oxycodone for chronic pain

Sep. 19, 2007

Cortex submits IND for Ampakine drug candidate CX-717 for ADHD

Sep. 18, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...